tiprankstipranks
Advertisement
Advertisement

ANNX Stock Latest News

Analyst Reiterates Buy on Annexon, Maintains $14 Price Target on Favorable ARCHER II Phase 3 Design
RatingsAnalyst Reiterates Buy on Annexon, Maintains $14 Price Target on Favorable ARCHER II Phase 3 Design
2d ago
ANNX
Analyst Reiterates Buy on Enhanced GA Strategy and GBS Upside, Maintaining $8 Price Target
PremiumRatings
Analyst Reiterates Buy on Enhanced GA Strategy and GBS Upside, Maintaining $8 Price Target
2d ago
ANNX
Annexon: Strategic Phase 3 Trial Flexibility Supports Buy Rating and Unchanged $25 Price Target
PremiumRatings
Annexon: Strategic Phase 3 Trial Flexibility Supports Buy Rating and Unchanged $25 Price Target
3d ago
ANNX
Annexon Biosciences highlights pivotal 2026 clinical progress
PremiumCompany Announcements
Annexon Biosciences highlights pivotal 2026 clinical progress
3d ago
8K
ANNX
Annexon Biosciences Adds Retinal Expert to Board
PremiumCompany Announcements
Annexon Biosciences Adds Retinal Expert to Board
4d ago
8K
ANNX
Annexon: Early FORWARD Study GBS Data Reinforce First-in-Class C1q Opportunity; Buy Rating and $14 Price Target Reaffirmed
PremiumRatingsAnnexon: Early FORWARD Study GBS Data Reinforce First-in-Class C1q Opportunity; Buy Rating and $14 Price Target Reaffirmed
8d ago
ANNX
Annexon announces tanruprubart data from FORWARD study
Premium
The Fly
Annexon announces tanruprubart data from FORWARD study
9d ago
ANNX
Annexon Highlights Promising Early FORWARD GBS Study Results
Premium
Company Announcements
Annexon Highlights Promising Early FORWARD GBS Study Results
9d ago
8K
ANNX
Annexon Biosciences Secures $200 Million Credit Facility
PremiumCompany Announcements
Annexon Biosciences Secures $200 Million Credit Facility
15d ago
8K
ANNX
Annexon initiated with an Underperform at Citizens
PremiumThe Fly
Annexon initiated with an Underperform at Citizens
25d ago
ANNX
Annexon price target raised to $25 from $11 at Needham
PremiumThe Fly
Annexon price target raised to $25 from $11 at Needham
1M ago
ANNX
Annexon to present vonaprument data at ASRS
PremiumThe Fly
Annexon to present vonaprument data at ASRS
1M ago
ANNX
Nedham biotech analysts hold an analyst/industry conference call
PremiumThe FlyNedham biotech analysts hold an analyst/industry conference call
1M ago
ANNX
Annexon Stockholders Approve Directors, Compensation and Share Increase
Premium
Company Announcements
Annexon Stockholders Approve Directors, Compensation and Share Increase
2M ago
8K
ANNX
Annexon initiated with a Neutral at Goldman Sachs
Premium
The Fly
Annexon initiated with a Neutral at Goldman Sachs
3M ago
ANNX
Annexon: Advancing Complement Pipeline and Strong Cash Runway Support Buy Rating; $11 Price Target Reiterated
PremiumRatings
Annexon: Advancing Complement Pipeline and Strong Cash Runway Support Buy Rating; $11 Price Target Reiterated
3M ago
ANNX
Annexon reports Q1 EPS (23c), consensus (30c)
PremiumThe Fly
Annexon reports Q1 EPS (23c), consensus (30c)
3M ago
ANNX
Cyber Risks Threaten Annexon Biosciences’ Clinical Operations, Reputation and Financial Health
PremiumCompany Announcements
Cyber Risks Threaten Annexon Biosciences’ Clinical Operations, Reputation and Financial Health
5M ago
ANNX
Chardan sees positive read-through to Annexon’s vonaprument from Apellis deal
PremiumThe Fly
Chardan sees positive read-through to Annexon’s vonaprument from Apellis deal
5M ago
ANNX
APLS
Annexon files automatic mixed securities shelf
PremiumThe FlyAnnexon files automatic mixed securities shelf
5M ago
ANNX
Annexon: Solid Cash Runway and 2026 Clinical Catalysts Underpin Buy Rating
Premium
Ratings
Annexon: Solid Cash Runway and 2026 Clinical Catalysts Underpin Buy Rating
5M ago
ANNX
Annexon (ANNX): Late‑Stage Complement Pipeline and Strong Cash Runway Support Attractive Risk‑Reward and Buy Rating
Premium
Ratings
Annexon (ANNX): Late‑Stage Complement Pipeline and Strong Cash Runway Support Attractive Risk‑Reward and Buy Rating
5M ago
ANNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >